Onconova Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer.
Traws Pharma stock last closed at $0.62, down 1.9% from the previous day, and has decreased 40.86% in one year. It has underperformed other stocks in the Biotechnology industry by 0.19 percentage points. Traws Pharma stock is currently +12.7% from its 52-week low of $0.55, and -57.17% from its 52-week high of $1.45.
At the moment, there are 21.04M TRAW shares outstanding. The market value of TRAW is $13.07M. In the past 24 hours, 44,540 TRAW shares were traded.
How to Buy Traws Pharma Stock
Not sure how to invest in Traws Pharma stock? Here's how.
Decide where to buy Traws Pharma stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Traws Pharma stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit money your investment account: Select your method of payment and add your info.
Evaluate Traws Pharma stock: The Traws Pharma ticker symbol is TRAW. Is Traws Pharma stock a good investment? Should you buy shares of TRAW? How do TRAW's underlying business fundamentals look? Do top analysts think Traws Pharma is a good buy? Why has TRAW's stock price moved recently? (Hint: Our stock analysis website can help you figure out if TRAW is a good stock to buy).
Make your TRAW trade: Decide if you will purchase TRAW shares at the current market price or use a limit order to purchase TRAW stock at a given price.
Get the latest news on your TRAW position: Create a watchlist to key updates about your investment in Traws Pharma stock.
Step 1: Decide where to buy Traws Pharma stock
You need an online brokerage account in order to access the NASDAQ market and buy TRAW stock.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you are able to buy TRAW today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Traws Pharma stock
After you have chosen the best place to buy Traws Pharma stock, it's absolutely critical to research their stock before you buy, so you actually comprehend the risk and upside.
Traws Pharma Metrics
TRAW Price
$0.62
1w %
-7.31%
1y %
-40.86%
5y %
-98.96%
P/E
-0.69x
P/B
1.22x
P/S
56.45x
PEG
N/A
Revenue
$226.00k
Earnings
-$18.95M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$13.07M
Next Earnings
May 13, 2024
Next Dividend
N/A
Traws Pharma Zen Score
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis quickly.
Last year, TRAW revenue was $226.00k. During the past 5 year, TRAW's revenue has increased by -28.72% per year. This was slower than the Biotechnology industry average of 28.56%.
What are TRAW executives and large shareholders up to?
Over the past year, insiders at TRAW have sold more shares than they have bought.
Steven M. Fruchtman, PRESIDENT CHIEF EXECUTIVE OFF of TRAW, was the latest TRAW insider to sell. They sold $7,854.30 worth of TRAW shares on Mar 14, 2024.
No, Traws Pharma doesn't provide an income stream by paying out dividends.
What do other traders have to say about TRAW?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your TRAW trade
You have two primary options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine for most investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a specific price, place a limit order.
Press the Open button and eToro will execute your order.
If you want more info about buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Traws Pharma share?
As of Apr 26, 2024, it costs $0.62 to buy one share of Traws Pharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.31, you can buy 0.5 shares of TRAW.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.